Do responses to news matter? Evidence from interventional cardiology.


Journal

Journal of health economics
ISSN: 1879-1646
Titre abrégé: J Health Econ
Pays: Netherlands
ID NLM: 8410622

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 05 02 2023
revised: 30 11 2023
accepted: 11 12 2023
medline: 18 3 2024
pubmed: 7 1 2024
entrez: 6 1 2024
Statut: ppublish

Résumé

We examine physician responses to a global information shock and how these impact their patients. We exploit international news over the safety of an innovation in healthcare, the drug-eluting stent. We use data on interventional cardiologists' use of stents to define and measure cardiologists' responsiveness to the initial positive news and link this to their patients' outcomes. We find substantial heterogeneity in responsiveness to news. Patients treated by cardiologists who respond slowly to the initial positive news have fewer adverse outcomes. This is not due to patient-physician sorting. Instead, our results suggest that the differences are partially driven by slow responders being better at deciding when (not) to use the new technology, which in turn affects their patient outcomes.

Identifiants

pubmed: 38183949
pii: S0167-6296(23)00123-6
doi: 10.1016/j.jhealeco.2023.102846
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102846

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniel Avdic (D)

Department of Economics, Deakin University, 70 Elgar Road, Burwood VIC 3125, Australia. Electronic address: d.avdic@deakin.edu.au.

Stephanie von Hinke (S)

School of Economics, University of Bristol, United Kingdom; IFS, United Kingdom.

Bo Lagerqvist (B)

UCR and SCAAR Study Group, Uppsala, Sweden.

Carol Propper (C)

IFS, United Kingdom; Imperial College Business School, Imperial College London, United Kingdom; Monash University, Australia; CEPR, United Kingdom.

Johan Vikström (J)

IFAU, Sweden; Uppsala University, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH